Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cocrystal Pharma Inc (NQ: COCP )

1.800 USD +0.290 (+19.21%)
Streaming Delayed Price Updated: 2:25 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cocrystal Pharma Inc

< Previous 1 2 3 4 5 6 Next >
Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement
From GlobeNewswire News Releases
Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium
From GlobeNewswire News Releases
Cocrystal Pharma to Present at Virtual NobleCon17 Conference on January 19, 2021
From GlobeNewswire News Releases
Cocrystal Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
From GlobeNewswire News Releases
Thinking about buying stock in Gevo Inc, Inovio Pharmaceuticals, Odonate Therapeutics, Cocrystal Pharma, or Vuzix Corp?
InvestorsObserver issues critical PriceWatch Alerts for GEVO, INO, ODT, COCP, and VUZI. 
From PR Newswire
Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses
From GlobeNewswire News Releases
Thinking about buying stock in Agios Pharmaceuticals, Clovis Oncology, Aqua Metals, Cocrystal Pharma, or Luminar Technologies?
InvestorsObserver issues critical PriceWatch Alerts for AGIO, CLVS, AQMS, COCP, and LAZR. 
From PR Newswire
Thinking about buying stock in Sutro Biopharma, BioCryst Pharmaceuticals, Inovio Pharmaceuticals, Cocrystal Pharma, or Clean Energy Fuels?
InvestorsObserver issues critical PriceWatch Alerts for STRO, BCRX, INO, COCP, and CLNE. 
From PR Newswire
Thinking about buying stock in Yunji, HP, Weidai, Cocrystal Pharma, or Mesa Air?
InvestorsObserver issues critical PriceWatch Alerts for YJ, HPQ, WEI, COCP, and MESA. 
From PR Newswire
Cocrystal Pharma Reports Third Quarter 2020 Financial Results and Provides Update on Antiviral Programs
From GlobeNewswire News Releases
Cocrystal Pharma Selected to Present at the World Antiviral Conference
From GlobeNewswire News Releases
Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference
From GlobeNewswire News Releases
Researchers Shift Focus to Progress Novel Vaccine Solutions
FinancialBuzz.com News Commentary 
From PR Newswire
Cocrystal Pharma Provides Update on Influenza A Program
From GlobeNewswire News Releases
Cocrystal Pharma Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
From GlobeNewswire News Releases
Cocrystal Pharma to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
From GlobeNewswire News Releases
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Cocrystal Pharma, Inc. and/or BioZone Pharmaceuticals, Inc. – COCP
From GlobeNewswire News Releases
Cocrystal Pharma Announces Closing of $17.2 Million Bought Deal Including Partial Exercise of Underwriter's Option to Purchase Additional Shares
From GlobeNewswire News Releases
Cocrystal Pharma Increases Previously Announced Bought Deal to $15.0 Million
From GlobeNewswire News Releases
Cocrystal Pharma Announces $10.0 Million Bought Deal Offering
From GlobeNewswire News Releases
Doctors Rely on Innovative Diagnostic Methods to Maintain the Spread of Infections
FinancialBuzz.com News Commentary 
From PR Newswire
U.S Stocks That Achieved Huge Gains Over The Past Week: $DRRX $BEAM $COCP
Tags The Market Signal
From The Market Signal
Cocrystal Pharma Reports Second Quarter 2020 Financial Results and Provides Updates on Antiviral Programs
From GlobeNewswire News Releases
Thinking about buying stock in YRC Worldwide, Cocrystal Pharma, Grupo Supervielle, FuelCell Energy, or Norwegian Cruise Line?
InvestorsObserver issues critical PriceWatch Alerts for YRCW, COCP, SUPV, FCEL, and NCLH. 
From PR Newswire
Cocrystal Pharma Announces the Publication by Collaborators of Positive Data Demonstrating Potent In Vitro Inhibition Against Coronavirus in Science Translational Medicine Journal
From GlobeNewswire News Releases
Wearable Tech Gives Rise to New Options in Healthcare
FinancialBuzz.com News Commentary 
From PR Newswire
Cocrystal Pharma Reports First Quarter 2020 Financial Results and Provides Updates on Antiviral Programs
From GlobeNewswire News Releases
Cocrystal Pharma Provides COVID-19 Impact Update on Development Programs
From GlobeNewswire News Releases
Cocrystal Pharma Expands Exclusive License Agreement with Kansas State University Research Foundation to New Coronavirus Antiviral Compounds with Novel Mechanism of Action
From GlobeNewswire News Releases
Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.